Browsing Tag
ophthalmic biosimilars
1 post
How Canada became the preferred launchpad for ophthalmic biosimilars in 2025
With Yesafili’s approval, Canada is emerging as the global launchpad for ophthalmic biosimilars. Explore what’s driving this strategic shift.